Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBJ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CK.2.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EE.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DB.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BW.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.110.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.23 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.9 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.74 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.621.1 (Mu)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.67NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CJ.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.6.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.7.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.3.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.464NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.234NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.231NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.243NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.517NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.291NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.349NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.314NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.132NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.99.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KT.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JC.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.334NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.359NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.302NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.222NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.434NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used